Healio11h
FDA approves Evrysdi tablets for spinal muscular atrophy
The FDA has approved Evrysdi in tablet form for patients with spinal muscular atrophy aged 2 years and older who weigh more ...
dvm3608h
Laverdia-CA1's field trial ends, statistical analysis to begin
Most major sections of the new animal drug application for Laverdia-CA1 have been deemed complete by the FDA, bringing the ...
FiercePharma2d
Roche scores FDA nod for Evrysdi tablets, bolstering convenience edge over rivals
Over the past nine years, patients with spinal muscular atrophy have seen the number of FDA-approved treatment options for ...
PMLiVE16h
Roche’s Evrysdi tablet formulation granted FDA approval for spinal muscular atrophy
Roche has announced that a tablet formulation of its spinal muscular atrophy (SMA) treatment Evrysdi (risdiplam) has been ...
Pharmabiz4d
Eton Pharma gets US patent covering its ET-600 product candidate’s proprietary formulation of desmopressin oral solution
Eton Pharma gets US patent covering its ET-600 product candidate’s proprietary formulation of desmopressin oral solution: Deer Park, Illinois Monday, February 10, 2025, 11:00 Hr ...
National Deworming Day 2025: Know About History, Significance, Date, & More
National Deworming Day (NDD) is an initiative launched by the Government of India in 2015 to combat parasitic worm infections ...